[-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study-Reference-Cited by-同舟云学术

[-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study

Published:2008-08 Issue:2 Volume:180 Page:539-543
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Sokoll Lori J.¹,Wang Yinghui²,Feng Ziding²,Kagan Jacob³,Partin Alan W.¹,Sanda Martin G.⁴,Thompson Ian M.⁵,Chan Daniel W.¹

Affiliation:

1. Departments of Pathology and Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland

2. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington

3. Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland

4. Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

5. Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Free prostate-specific antigen in serum is becoming more complex;Mikolajczyk;Urology,2002

2. A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue;Mikolajczyk;Cancer Res,2000

3. Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer;Mikolajczyk;Clin Chem,2004

4. “BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia;Mikolajczyk;Urology,2000

5. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid;Zhang;Clin Chem,1995

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Biofluid Assays for Prostate Cancer;Cancers;2023-12-28

2. Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification;Urologic Oncology: Seminars and Original Investigations;2023-11

3. The utility of the [−2]pro‐prostate‐specific antigen level as a prognostic marker in patients with castration‐resistant prostate cancer treated with enzalutamide;International Journal of Urology;2023-05-31

4. Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA);Annales de Biologie Clinique;2023-02

5. Advances in Early Diagnosisand Treatment of Prostate Cancer;Hans Journal of Biomedicine;2023